Rice Hall James & Associates LLC Cuts Position in Transcat, Inc. (NASDAQ:TRNS)

Rice Hall James & Associates LLC reduced its holdings in shares of Transcat, Inc. (NASDAQ:TRNS) by 0.8% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 25,447 shares of the scientific and technical instruments company’s stock after selling 212 shares during the period. Rice Hall James & Associates LLC’s holdings in Transcat were worth $3,073,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. DekaBank Deutsche Girozentrale acquired a new position in shares of Transcat during the 2nd quarter valued at $40,000. nVerses Capital LLC purchased a new position in Transcat in the third quarter valued at about $60,000. First Horizon Advisors Inc. raised its position in Transcat by 26.4% in the second quarter. First Horizon Advisors Inc. now owns 599 shares of the scientific and technical instruments company’s stock valued at $72,000 after purchasing an additional 125 shares during the period. Fifth Third Bancorp lifted its stake in shares of Transcat by 95.8% during the second quarter. Fifth Third Bancorp now owns 656 shares of the scientific and technical instruments company’s stock worth $79,000 after purchasing an additional 321 shares in the last quarter. Finally, Quest Partners LLC acquired a new stake in shares of Transcat in the second quarter valued at about $109,000. Institutional investors and hedge funds own 98.34% of the company’s stock.

Analysts Set New Price Targets

TRNS has been the topic of several recent research reports. Craig Hallum reduced their price target on Transcat from $138.00 to $113.00 and set a “buy” rating on the stock in a research report on Wednesday. HC Wainwright restated a “buy” rating and issued a $156.00 target price on shares of Transcat in a research note on Tuesday. StockNews.com downgraded shares of Transcat from a “hold” rating to a “sell” rating in a research note on Tuesday. Oppenheimer reissued an “outperform” rating and issued a $130.00 price objective (down from $155.00) on shares of Transcat in a research report on Wednesday. Finally, Northland Securities dropped their target price on Transcat from $130.00 to $110.00 and set a “market perform” rating on the stock in a research report on Wednesday. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $127.25.

Transcat Price Performance

NASDAQ TRNS opened at $95.41 on Friday. The company has a market capitalization of $873.00 million, a price-to-earnings ratio of 48.19 and a beta of 0.69. Transcat, Inc. has a 12 month low of $84.45 and a 12 month high of $147.12. The company’s fifty day moving average price is $121.71 and its two-hundred day moving average price is $121.89.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.12). Transcat had a return on equity of 7.62% and a net margin of 6.63%. The company had revenue of $67.83 million for the quarter, compared to the consensus estimate of $70.30 million. During the same period in the previous year, the business posted $0.41 EPS. The business’s revenue for the quarter was up 8.0% on a year-over-year basis. As a group, analysts anticipate that Transcat, Inc. will post 1.76 EPS for the current year.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.